Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.

Sullivan HW, O'Donoghue AC, Lynch M, Johnson M, Davis C, Rupert DJ.

Med Decis Making. 2019 Oct 4:272989X19875946. doi: 10.1177/0272989X19875946. [Epub ahead of print]

PMID:
31583947
2.

Aging and Direct-to-Consumer Prescription Drug Television Ads: The Effects of Individual Differences and Risk Presentation.

O'Donoghue AC, Johnson M, Sullivan HW, Parvanta S, Ray S, Southwell BG.

J Health Commun. 2019;24(4):368-376. doi: 10.1080/10810730.2019.1606364. Epub 2019 Apr 23.

PMID:
31012394
3.

Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.

DeFrank JT, Berkman ND, Kahwati L, Cullen K, Aikin KJ, Sullivan HW.

Health Commun. 2019 Apr 11:1-8. doi: 10.1080/10410236.2019.1584781. [Epub ahead of print]

PMID:
30973021
4.

Actors in whitespace: Communicating risk information on pharmaceutical websites.

O'Donoghue AC, Sullivan HW, Rupert DJ, Fitts Willoughby J, Aikin KJ.

Health Mark Q. 2019 Apr-Jun;36(2):152-167. doi: 10.1080/07359683.2019.1575063. Epub 2019 Mar 23.

PMID:
30907290
5.

Disclosing accelerated approval on direct-to-consumer prescription drug websites.

Sullivan HW, O'Donoghue AC, David KT, Patel NJ.

Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1277-1280. doi: 10.1002/pds.4664. Epub 2018 Sep 28.

PMID:
30264874
6.

Assessing hearing and cognition challenges in consumer processing of televised risk information: Validation of self-reported measures using performance indicators.

Southwell BG, Parvanta SA, Johnson MM, O'Donoghue AC, Sullivan HW, Ray SE, Soloe CS, Davis CN, McKenna N.

Prev Med Rep. 2018 Jun 22;11:145-147. doi: 10.1016/j.pmedr.2018.06.008. eCollection 2018 Sep.

7.

Physicians' Understanding of Clinical Trial Data in Professional Prescription Drug Promotion.

Moynihan CK, Burke PA, Evans SA, O'Donoghue AC, Sullivan HW.

J Am Board Fam Med. 2018 Jul-Aug;31(4):645-649. doi: 10.3122/jabfm.2018.04.170242.

8.

Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions.

Sullivan HW, O'Donoghue AC, Gard Read J, Amoozegar JB, Aikin KJ, Rupert DJ.

J Med Internet Res. 2018 Jan 23;20(1):e13. doi: 10.2196/jmir.7959.

9.

Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis.

Sullivan HW, Aikin KJ, Poehlman J.

Health Commun. 2019 Feb;34(2):212-219. doi: 10.1080/10410236.2017.1399509. Epub 2017 Nov 10.

PMID:
29125325
10.

Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis.

Aikin KJ, Sullivan HW, Dolina S, Lynch M, Squiers LB.

J Med Internet Res. 2017 Jul 4;19(7):e225. doi: 10.2196/jmir.7306.

11.

Prescribers' Knowledge and Skills for Interpreting Research Results: A Systematic Review.

Kahwati L, Carmody D, Berkman N, Sullivan HW, Aikin KJ, DeFrank J.

J Contin Educ Health Prof. 2017 Spring;37(2):129-136. doi: 10.1097/CEH.0000000000000150. Review.

PMID:
28562502
12.

Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.

Sullivan HW, O'Donoghue AC, Rupert DJ, Willoughby JF, Aikin KJ.

J Health Commun. 2017 Feb;22(2):171-181. doi: 10.1080/10810730.2016.1258745. Epub 2017 Jan 27.

PMID:
28129069
13.

Consumer confusion between prescription drug precautions and side effects.

Amoozegar JB, Rupert DJ, Sullivan HW, O'Donoghue AC.

Patient Educ Couns. 2017 Jun;100(6):1111-1119. doi: 10.1016/j.pec.2016.12.032. Epub 2016 Dec 30.

PMID:
28069321
14.

Consumer perceptions of prescription and over-the-counter drug advertisements with promotional offers.

Aikin KJ, Sullivan HW, O'Donoghue AC, Betts KR.

Health Mark Q. 2016 Oct-Dec;33(4):291-306. Epub 2016 Oct 19.

PMID:
27841741
15.

Peer-Generated Health Information: The Role of Online Communities in Patient and Caregiver Health Decisions.

Rupert DJ, Gard Read J, Amoozegar JB, Moultrie RR, Taylor OM, O'Donoghue AC, Sullivan HW.

J Health Commun. 2016 Nov;21(11):1187-1197. Epub 2016 Nov 2.

PMID:
27805496
16.

Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study.

Sullivan HW, O'Donoghue AC, Rupert DJ, Willoughby JF, Amoozegar JB, Aikin KJ.

J Health Commun. 2016 Nov;21(11):1198-1207. Epub 2016 Nov 2.

PMID:
27805473
17.

Quantitative Information on Oncology Prescription Drug Websites.

Sullivan HW, Aikin KJ, Squiers LB.

J Cancer Educ. 2018 Apr;33(2):371-374. doi: 10.1007/s13187-016-1107-1.

18.

Consumers' Understanding of FDA Approval Requirements and Composite Scores in Direct-to-Consumer Prescription Drug Print Ads.

O'Donoghue AC, Sullivan HW, Williams PA, Squire C, Betts KR, Fitts Willoughby J, Parvanta S.

J Health Commun. 2016 Aug;21(8):927-34. doi: 10.1080/10810730.2016.1179367. Epub 2016 Jul 14.

PMID:
27414000
19.

Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration.

Sullivan HW, Aikin KJ, Chung-Davies E, Wade M.

PLoS One. 2016 May 5;11(5):e0155035. doi: 10.1371/journal.pone.0155035. eCollection 2016.

20.

Who Said It Better? A Test of Wording Differences in the MedWatch "Toll-Free Statement" for Consumer Reporting of Side Effects in Direct-to-Consumer Television Advertisements.

Aikin KJ, O'Donoghue AC, Sullivan HW, Betts KR, Squire C.

Ther Innov Regul Sci. 2016 Mar;50(2):169-173. doi: 10.1177/2168479015596023.

PMID:
30227007
21.

Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.

Sullivan HW, O'Donoghue AC, Aikin KJ, Chowdhury D, Moultrie RR, Rupert DJ.

Patient Educ Couns. 2016 May;99(5):790-9. doi: 10.1016/j.pec.2015.12.015. Epub 2015 Dec 22.

PMID:
26749356
22.

Disease Information in Direct-to-Consumer Prescription Drug Print Ads.

Aikin KJ, Sullivan HW, Betts KR.

J Health Commun. 2016;21(2):228-39. doi: 10.1080/10810730.2015.1058440. Epub 2015 Dec 30.

PMID:
26717304
23.

Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.

Williams PA, O'Donoghue AC, Sullivan HW, Willoughby JF, Squire C, Parvanta S, Betts KR.

Patient Educ Couns. 2016 Apr;99(4):583-590. doi: 10.1016/j.pec.2015.10.019. Epub 2015 Nov 5.

PMID:
26589655
24.

Communicating Benefit and Risk Information in Direct-to-Consumer Print Advertisements: A Randomized Study.

Sullivan HW, O'Donoghue AC, Aikin KJ.

Ther Innov Regul Sci. 2015 Jul;49(4):493-502. doi: 10.1177/2168479015572370.

PMID:
30222437
25.

Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration.

Sullivan HW, Campbell M.

J Health Commun. 2015;20(12):1391-6. doi: 10.1080/10810730.2015.1018635. Epub 2015 Jun 29.

PMID:
26120940
26.

Primary care physicians' use of FDA-approved prescription drug labels.

Sullivan HW, O'Donoghue AC, Aikin KJ.

J Am Board Fam Med. 2014 Sep-Oct;27(5):694-8. doi: 10.3122/jabfm.2014.05.140039.

27.

Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.

O'Donoghue AC, Williams PA, Sullivan HW, Boudewyns V, Squire C, Willoughby JF.

Soc Sci Med. 2014 Nov;120:1-11. doi: 10.1016/j.socscimed.2014.08.039. Epub 2014 Aug 28.

PMID:
25194471
28.

Perceived healthcare provider reactions to patient and caregiver use of online health communities.

Rupert DJ, Moultrie RR, Read JG, Amoozegar JB, Bornkessel AS, O'Donoghue AC, Sullivan HW.

Patient Educ Couns. 2014 Sep;96(3):320-6. doi: 10.1016/j.pec.2014.05.015. Epub 2014 May 29.

PMID:
24923652
29.

Important Safety Information or Important Risk Information? A Question of Framing in Prescription Drug Advertisements.

O'Donoghue AC, Sullivan HW, Aikin KJ, Betts KR.

Ther Innov Regul Sci. 2014 May;48(3):305-307. doi: 10.1177/2168479013510306.

PMID:
30235532
30.

Randomized study of placebo and framing information in direct-to-consumer print advertisements for prescription drugs.

O'Donoghue AC, Sullivan HW, Aikin KJ.

Ann Behav Med. 2014 Dec;48(3):311-22. doi: 10.1007/s12160-014-9603-1.

PMID:
24682975
31.

Presenting efficacy information in direct-to-consumer prescription drug advertisements.

O'Donoghue AC, Sullivan HW, Aikin KJ, Chowdhury D, Moultrie RR, Rupert DJ.

Patient Educ Couns. 2014 May;95(2):271-80. doi: 10.1016/j.pec.2013.12.010. Epub 2013 Dec 25.

PMID:
24581929
32.

Presenting quantitative information about placebo rates to patients.

Sullivan HW, O'Donoghue AC, Aikin KJ.

JAMA Intern Med. 2013 Nov 25;173(21):2006-7. doi: 10.1001/jamainternmed.2013.10399. No abstract available.

PMID:
24126622
33.

Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising.

West SL, Squiers LB, McCormack L, Southwell BG, Brouwer ES, Ashok M, Lux L, Boudewyns V, O'Donoghue A, Sullivan HW.

Pharmacoepidemiol Drug Saf. 2013 May;22(5):447-58. doi: 10.1002/pds.3416. Epub 2013 Feb 26. Review.

PMID:
23440924
34.

Randomized trial of risk information formats in direct-to-consumer prescription drug advertisements.

Aikin KJ, O'Donoghue AC, Swasy JL, Sullivan HW.

Med Decis Making. 2011 Nov-Dec;31(6):E23-33. doi: 10.1177/0272989X11413289. Epub 2011 Jun 20.

PMID:
21690303
35.

Requests for cancer prevention information: the cancer information service (2002-2006).

Sullivan HW, Finney Rutten LJ, Waters EA.

J Cancer Educ. 2010 Mar;25(1):16-22. doi: 10.1007/s13187-009-0003-3.

36.

Lay representations of cancer prevention and early detection: associations with prevention behaviors.

Sullivan HW, Rutten LJ, Hesse BW, Moser RP, Rothman AJ, McCaul KD.

Prev Chronic Dis. 2010 Jan;7(1):A14. Epub 2009 Dec 15.

37.

Cancer prevention information seeking: a signal detection analysis of data from the cancer information service.

Sullivan HW, Finney Rutten LJ.

J Health Commun. 2009 Dec;14(8):785-96. doi: 10.1080/10810730903295534.

PMID:
20029711
38.

What is my cancer risk? How internet-based cancer risk assessment tools communicate individualized risk estimates to the public: content analysis.

Waters EA, Sullivan HW, Nelson W, Hesse BW.

J Med Internet Res. 2009 Jul 31;11(3):e33. doi: 10.2196/jmir.1222.

39.
40.

Nutrition-related cancer prevention cognitions and behavioral intentions: testing the risk perception attitude framework.

Sullivan HW, Burke Beckjord E, Finney Rutten LJ, Hesse BW.

Health Educ Behav. 2008 Dec;35(6):866-79. doi: 10.1177/1090198108326164.

41.
42.

When planning is needed: Implementation intentions and attainment of approach versus avoidance health goals.

Sullivan HW, Rothman AJ.

Health Psychol. 2008 Jul;27(4):438-44. doi: 10.1037/0278-6133.27.4.438.

PMID:
18643001
43.

Nutrition-related cancer prevention attitudes in low-income women.

Sullivan HW, Klassen AC.

Prev Med. 2007 Aug-Sep;45(2-3):139-45. Epub 2007 May 21.

PMID:
17604830
44.

The mediating role of parental expectations in culture and well-being.

Oishi S, Sullivan HW.

J Pers. 2005 Oct;73(5):1267-94.

PMID:
16138873
45.

Relationship of omeprazole-induced hypergastrinemia to gastric pH.

Larson GM, Sullivan HW, Rayford PL.

Surgery. 1986 Aug;100(2):175-80.

PMID:
3738749
46.

Omeprazole-induced hypergastrinemia: role of gastric acidity.

Larson GM, Sullivan HW, Rayford P.

J Surg Res. 1986 May;40(5):504-9.

PMID:
3736035
47.

Surgical sympathectomy increases pancreatic polypeptide response to food.

Larson GM, Sullivan HW, O'Dorisio T.

Surgery. 1985 Aug;98(2):236-42.

PMID:
4023921
48.

Omeprazole, a long-lasting inhibitor of gastric secretion.

Larson GM, Sullivan HW Jr.

J Surg Res. 1984 May;36(5):503-7.

PMID:
6727328
49.

Ion transport by rabbit jejunum in vivo.

Fromm D, Dibala RP, Sullivan HW Jr.

Am J Physiol. 1975 Jan;228(1):160-5.

PMID:
1147007

Supplemental Content

Loading ...
Support Center